Data Submission Format Sample Clauses

Data Submission Format. 9.1.1. Contractor shall submit and keep current all products, service and pricing data in the format described in Attachment 8 (as amended from time to time) for publication in all web and other methods for internal and private display and access.
AutoNDA by SimpleDocs
Data Submission Format. Scope Complete product data, which facilitates VRR’s ability to correctly order and identify product, must be provided. Your merchant will direct you towards the appropriate level of data requested for the build sheet. Each high-level bullet point must be delimited into its own cell/column. For some product types, additional or fewer data points will be required and will be detailed in a request from a member of the VRR team. • UPC/EAN/GTIN – o Numeric, 8-15 digits o 12-digit, UPCs preferred;  If your brand has both EANs and UPCs, send only UPCs.  If your brand has both shortened UPCs (8 digits) used for tagging; include both the shortened 8-digit UPC and the full 12-digit UPC.  UPCs must include valid check digit. o Include all leading zeros;  UPCs must be 12 digits.  EANs must be 13 digits.  GTINs must be 14 digits. o UPCs must be specific to the product they are first assigned to and cannot be re-used in future seasons for different product. • Style Number/Part Number/Model Code – o Alphanumeric, 1-15 characters o Model level (not color/size/dimension specific) product identifier. o If letters are present in style number, they must be in all caps. • Item Description – o Alphanumeric, 1-30 characters o Item name as listed on customer-facing websites (no abbreviations, truncations, or shortened descriptions) • Extended Item Description – o Alphanumeric, no max o Intended for use on customer-facing ecommerce websites. Usually a couple of sentences. • Product size code – o Alphanumeric, 1-15 characters o Examples: S, M, L, 215cm, One, etc. • Product size number – o Numeric (real), no max o NRF size code • Product size description –o Alphanumeric, no max o Examples: Small, Medium, Large, 215cm, One Size, etc. • Product dimension or additional size code – o Alphanumeric, 1-15 characters o Examples: pant length (S, R, L), waist size (30, 36) shoe width (M, W), snowboard width (Wide), etc. UPC/EAN/GTIN – o Numeric, 8-15 digits o 12-digit, UPCs preferred;  If your brand has both EANs and UPCs, send only UPCs.  If your brand has both shortened UPCs (8 digits) used for tagging; include both the shortened 8-digit UPC and the full 12-digit UPC.  UPCs must include valid check digit. o Include all leading zeros;  UPCs must be 12 digits.  EANs must be 13 digits.  GTINs must be 14 digits. o UPCs must be specific to the product they are first assigned to and cannot be re-used in future seasons for different product. • Style Number/Part Number/Model Code – o A...
Data Submission Format. 9.1.1.Contractor shall submit and keep current all products, service and pricing data in the format described in Attachment A (amended by the Government from time to time as required) for publication in all web and other methods for public and private display and access.
Data Submission Format. Licensee shall ensure that all data fields are complete for each patient rating and submission. Licensee acknowledges that incomplete or inaccurate data may skew reports. If Medirisk's data error process indicates that data is incomplete or inaccurate, Licensee may be requested to provide additional data; failure of Licensee to timely submit such data may result in a delay in the production of applicable reports, which delay shall not be actionable by Licensee. In order to facilitate data submission, Licensee agrees to assign a staff member at each facility to the role of Data Collection Coordinator with respect to Medirisk. This staff member shall have primary responsibility for, and primary contact with Medirisk regarding, data submission. Licensee agrees to provide the name, telephone, and fax numbers of each such person to Medirisk via each completed Facility Enrollment Form. Licensee agrees to reassign this responsibility to another staff member, when appropriate, and to use good faith efforts to promptly inform Medirisk of each such change. Medirisk shall likewise identify to each Data Collection Coordinator his or her primary contact at Medirisk, along with such person's telephone and fax numbers.

Related to Data Submission Format

  • Protocol No action to coerce or censor or penalize any negotiation participant shall be made or implied by any other member as a result of participation in the negotiation process.

  • Commercialization Reports Throughout the term of this Agreement and during the Sell-Off Period, and within thirty (30) days of December 31st of each year, Company will deliver to University written reports of Company’s and Sublicensees’ efforts and plans to develop and commercialize the innovations covered by the Licensed Rights and to make and sell Licensed Products. Company will have no obligation to prepare commercialization reports in years where (a) Company delivers to University a written Sales Report with active sales, and (b) Company has fulfilled all Performance Milestones. In relation to each of the Performance Milestones each commercialization report will include sufficient information to demonstrate achievement of those Performance Milestones and will set out timeframes and plans for achieving those Performance Milestones which have not yet been met.

  • Access to Review Materials The Servicer will give the Asset Representations Reviewer access to the Review Materials for all of the Subject Receivables within sixty (60) calendar days after receipt of the review notice in one or more of the following ways in the Servicer’s reasonable discretion: (i) by electronic posting of Review Materials to a password-protected website to which the Asset Representations Reviewer has access, (ii) by providing originals or photocopies of documents relating to the Subject Receivables at one of the properties of the Servicer or (iii) in another manner agreed by the Servicer and the Asset Representations Reviewer. The Servicer may redact or remove PII from the Review Materials so long as all information in the Review Materials necessary for the Asset Representations Reviewer to complete the Asset Review remains intact and unchanged.

  • Commercialization Plan The JCC will oversee the Commercialization of Shared Products by the Parties in the Field in the Territory. No later than [***] prior to the anticipated launch of the Shared Product in the first country in the Territory, the JCC will develop and submit to the JSC for approval, a Commercialization plan (the “Commercialization Plan”) that sets forth the Commercialization activities to be undertaken by the Parties with respect to the Commercialization of the Shared Product in the Territory. The Commercialization Plan may include activities on a region-by-region or country-by-country basis, as determined by the JCC. The JCC will update the Commercialization Plan on [***] (or more frequently as needed) and submit it to the JSC for approval. The Commercialization Plan will include (a) the Global Branding Strategy, (b) a marketing strategy, (c) a communications strategy that includes plans for public relations, conferences and exhibitions and other external meetings, internal meetings and communications, publications and symposia, internet activities and core brand package, (d) a high level operating plan for the implementation of such strategies on [***], including information related to Shared Product positioning, core messages to be communicated and pricing strategies, (e) a detailing strategy, (f) a pricing strategy, (g) all other material activities to be conducted in connection with the Commercialization of the Shared Product in the Field in the Territory and (h) a budget for activities conducted under the Commercialization Plan (the “Commercialization Budget”). The Commercialization Plan will include a meaningful role for both Parties. In allocating responsibilities between the Parties, the JCC will take into consideration each Party’s expertise, capabilities, staffing and available resources to take on such activities, as well as the Parties’ intention to provide CRISPR an opportunity to build and expand its expertise, capabilities, staffing and available resources in connection with performing Commercialization activities allocated to it. CRISPR shall be the Commercializing lead for Shared Products in the United States and Vertex shall be the Commercializing lead for Shared Products outside of the United States. The Commercializing lead, with respect to the United States or outside of the United States, respectively, shall be referred to herein as the “Lead Commercialization Party” for such jurisdiction (as applicable, the “Lead Commercialization Party” Unless otherwise specified in the Commercialization Plan, the Parties will jointly be responsible for conducting all Commercialization activities outside of the United States, such activities to be determined by the JSC.

  • Director Notification Information If you are a director of a Singapore Subsidiary, you may need to notify the Singapore Subsidiary in writing within two business days of your receiving an interest (e.g., Performance Units) in the Company or any Subsidiary or within two business days of you becoming a director if such an interest exists at the time. This notification requirement also applies to an associate director of the Singapore Subsidiary and to a shadow director of the Singapore Subsidiary (i.e., an individual who is not on the board of directors of the Singapore Subsidiary but who has sufficient control so that the board of directors of the Singapore Subsidiary acts in accordance with the “directions and instructions” of the individual). US/INTERNATIONAL EMPLOYEE (EXHIBIT B) SOUTH AFRICA KBR, INC. 2006 STOCK AND INCENTIVE PLAN

  • Information for Regulatory Compliance Each of the Company and the Depositary shall provide to the other, as promptly as practicable, information from its records or otherwise available to it that is reasonably requested by the other to permit the other to comply with applicable law or requirements of governmental or regulatory authorities.

  • Additional Submissions – Information Access The claimant shall then have the opportunity to submit written comments, documents, records and other information relating to the claim. The Company shall also provide the claimant, upon request and free of charge, reasonable access to, and copies of, all documents, records and other information relevant (as defined in applicable ERISA regulations) to the claimant’s claim for benefits.

  • Maintenance of Review Materials It will maintain copies of any Review Materials, Review Reports and other documents relating to a Review, including internal correspondence and work papers, for a period of at least two years after any termination of this Agreement.

Time is Money Join Law Insider Premium to draft better contracts faster.